Preoperative Chemoradiotherapy and Toripalimab in Locally Recurrent Rectal Cancer

NCT06751394 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Rectal Cancer

Interventions

DRUG: PD-1 antibody (Toripalimab)
DRUG: Capecitabine
DRUG: Oxaliplatin
DRUG: Irinotecan
RADIATION: Radiation
PROCEDURE: surgery

Sponsor

Sixth Affiliated Hospital, Sun Yat-sen University